Overlapping gene expression in fetal mouse intestine development and human colorectal cancer

Cancer Research

Volumn 65, Issue 19, 2005, Pages 8715-8722

  Hu, Michael ^a   Shivdasani, Ramesh A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; EPITHELIUM CELL; FETUS DEVELOPMENT; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; INTESTINE; MAJOR CLINICAL STUDY; MORPHOGENESIS; ORGANOGENESIS; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS; TISSUE SPECIFICITY;

ANIMALS; COLORECTAL NEOPLASMS; DATA INTERPRETATION, STATISTICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINES; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 25444491191     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0700     Document Type: Article

References (35)

1. Lum L, Beachy PA. The Hedgehog response network: sensors, switches, and routers. Science 2004;304:1755-9.
2. Sancho E, Batlle E, Clevers H. Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 2004;20:695-723.
3. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99.
4. Garrett PE, Kurtz SR. Clinical utility of oncofetal proteins and hormones as tumor markers. Med Clin North Am 1986;70:1295-306.
5. Duffy MJ. Evidence for the clinical use of tumour markers. Ann Clin Biochem 2004;41:370-7.
6. Kho AT, Zhao Q, Cai Z, et al. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev 2004;18:629-40.
7. Stappenbeck TS, Wong MH, Saam JR, Mysorekar IU, Gordon JI. Notes from some crypt watchers: regulation of renewal in the mouse intestinal epithelium. Curr Opin Cell Biol 1998;10:702-9.
8. Potten CS, Booth C, Pritchard DM. The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol 1997;78:219-43.
9. Velculescu VE, Zhang L, Vogelstein B, Kanzler KW. Serial analysis of gene expression. Science 1995;270:484-7.
10. Lepourcelet M, Tou L, Cai L, et al. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF). Development 2005;132:415-27.
11. Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004;6:1-6.
12. Zhang L, Zhou W, Velculescu VE, et al. Gene expression profiles in normal and cancer cells. Science 1997;276:1268-72.
13. Alon U, Barkai N, Notterman DA, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A 1999;96:6745-50.
14. Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001;61:3124-30.
15. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 2001;98:15149-54.
16. Lal A, Lash AE, Altschul SF, et al. A public database for gene expression in human cancers. Cancer Res 1999;59:5403-7.
17. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 2003;100:5974-9.
18. Chen X, Cheung ST, So S, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002;13:1929-39.
19. Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002;1:203-9.
20. De Vos J, Thykjaer T, Tarte K, et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 2002;21:6848-57.
21. Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002;3:298-302.
22. Uriel J. Fetal characteristics of cancer. 3rd ed. In: Becker FF, editor. Cancer, a comprehensive treatise. New York: Plenum Press; 1975.
23. Rubin H. Cancer as a dynamic developmental disorder. Cancer Res 1985;45:2935-42.
24. Needham J. New advances in the chemistry and biology of organized growth. Proc R Soc Lond B Biol Sci 1936;39:1577-626.
25. Waddington CH. Cancer and the theory of organizers. Nature 1935;135:606-8.
26. Gaudet F, Hodgson JG, Eden A, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003;300:489-92.
27. Mihich E, Jaenisch R. Sixteenth Annual Pezcoller Symposium: stem cells and epigenesis in cancer. Cancer Res 2004;64:8474-7.
28. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
29. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985;228:187-90.
30. Loging WT, Reisman D. Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53. Cancer Epidemiol Biomarkers Prev 1999;8:1011-6.
31. Kondoh N, Shuda M, Tanaka K, Wakatsuki T, Hada A, Yamamoto M. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma. Anticancer Res 2001;21:2429-33.
32. Amsterdam A, Sadler KC, Lai K, et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2004;2:690-8.
33. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer 2003;3:179-92.
34. Cui H, Cruz-Correa M, Giardiello FM, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk, Science 2003;299:1753-5.
35. Cai L, Huang H, Blackshaw S, Liu JS, Cepko C, Wong WH. Clustering analysis of SAGE data using a Poisson approach. Genome Biol 2004;5:R51.